(Q51568029)

7 April 2018

review article

1 reference

title

Implications of blood glucose, insulin resistance and beta-cell function in impaired glucose tolerance. (English)

1 reference

7 April 2018

0 references

1 reference

B Göke

1

1 reference

7 April 2018

publication date

1 July 1998

1 reference

7 April 2018

Diabetes Research and Clinical Practice

published in

1 reference

7 April 2018

volume

40 Suppl

1 reference

7 April 2018

page(s)

S15-20

1 reference

7 April 2018

Science, medicine, and the future. Non-insulin dependent diabetes mellitus: the gathering storm

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2898%2900037-0

7 January 2021

Prevalence and secular trends in obesity in Pacific and Indian Ocean island populations

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2898%2900037-0

7 January 2021

Preventing non-insulin-dependent diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2898%2900037-0

7 January 2021

Impaired glucose tolerance as a disorder of insulin action. Longitudinal and cross-sectional studies in Pima Indians.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2898%2900037-0

7 January 2021

The natural history of impaired glucose tolerance in the Pima Indians.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2898%2900037-0

7 January 2021

Diabetes mellitus in the Pima Indians: incidence, risk factors and pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2898%2900037-0

7 January 2021

A two-step model for development of non-insulin-dependent diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2898%2900037-0

7 January 2021

Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2898%2900037-0

7 January 2021

Undiagnosed diabetes or impaired glucose tolerance and cardiovascular risk

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2898%2900037-0

7 January 2021

Diabetes, asymptomatic hyperglycemia, and 22-year mortality in black and white men. The Chicago Heart Association Detection Project in Industry Study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2898%2900037-0

7 January 2021

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2898%2900037-0

7 January 2021

Relationships Between Fasting Plasma Glucose Levels and Insulin Secretion During Intravenous Glucose Tolerance Tests

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2898%2900037-0

7 January 2021

Coronary-heart-disease risk and impaired glucose tolerance. The Whitehall study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2898%2900037-0

7 January 2021

Visual Impairment and Retinopathy in People With Normal Glucose Tolerance, Impaired Glucose Tolerance, and Newly Diagnosed NIDDM

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2898%2900037-0

7 January 2021

Does hyperglycaemia or hyperinsulinaemia characterise the patient with chemical diabetes?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2898%2900037-0

7 January 2021

The pathophysiology of diabetic complications: how much does the glucose hypothesis explain?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2898%2900037-0

7 January 2021

Glycosylated hemoglobin predicts the incidence and progression of diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2898%2900037-0

7 January 2021

Hyperglycemia and microvascular and macrovascular disease in diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2898%2900037-0

7 January 2021

The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2898%2900037-0

7 January 2021

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2898%2900037-0

7 January 2021

Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2898%2900037-0

7 January 2021

alpha-Glucosidase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2898%2900037-0

7 January 2021

Chronic hyperglycemia is associated with impaired glucose influence on insulin secretion. A study in normal rats using chronic in vivo glucose infusions

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2898%2900037-0

7 January 2021

Does hyperglycemia really cause coronary heart disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2898%2900037-0

7 January 2021

Glycemic control and the risk for coronary heart disease in patients with non-insulin-dependent diabetes mellitus. The Finnish studies

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2898%2900037-0

7 January 2021

Banting lecture 1988. Role of insulin resistance in human disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2898%2900037-0

7 January 2021

Pathophysiology of insulin resistance in human disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2898%2900037-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS0168-8227%2898%2900037-0

1 reference

7 January 2021

Insulin resistance is central to the burden of diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2898%2900037-0

7 January 2021

Insulin resistance is not central to the burden of diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2898%2900037-0

7 January 2021

Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2898%2900037-0

7 January 2021

The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2898%2900037-0

7 January 2021

Acute and chronic effects of hyperglycaemia on glucose metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2898%2900037-0

7 January 2021

An integrated view of beta-cell dysfunction in type-II diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2898%2900037-0

7 January 2021

Plasma Insulin Responses to Oral and Intravenous Glucose: Studies in Normal and Diabetic Subjects*

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2898%2900037-0

7 January 2021

Relationship of glycosylated hemoglobin to oral glucose tolerance. Implications for diabetes screening

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/citations/10.2337/DIABETES.37.1.60

Identifiers

DOI

10.1016/S0168-8227(98)00037-0

1 reference

7 April 2018

1 reference

7 April 2018